Intrinsic Value

The intrinsic value of RH Bophelo Ltd (RHB) under the Base Case is 521.33 Zac per share. Compared with the current market price of 120 Zac, the stock appears Undervalued by 77% .

The intrinsic value is calculated using the DCF method. The model assumes revenue grows about -4% a year over the next five years, less than a third of its five-year pace of 44%. Net margin ends at 41% by 2033, below its five-year average of 147%.

Do our valuations actually work? See backtest results .

RHB Intrinsic Value
521.33 Zac
Undervaluation 77%
Intrinsic Value
Price 120 Zac
Alert me when RHB is below its intrinsic value
Today 417.07 · Already reached, the price is 71.2% below it

RHB is cheaper than usual. It was this cheap or cheaper on just 4% of days in the past 5 years.

Alternatives to RHB

Fundamental Analysis

What RH Bophelo Does

Financial Services Financials

RH Bophelo Ltd is a South African company that owns and invests in healthcare businesses. Its main role is to back hospitals, clinics, and other medical service assets rather than to run a consumer-facing brand itself. For beginner investors, think of it as a healthcare owner and capital provider inside the medical services chain.

Headquarters
South Africa ZA
IPO date
Jul 12, 2017
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
RH Bophelo Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one RHB stock?

The intrinsic value for RH Bophelo Ltd (RHB) under the Base Case is 521.33 Zac.

Is RHB stock undervalued or overvalued?

Compared with the current market price of 120 Zac, the stock appears Undervalued by 77% .

Back to Top